Search

The art of innovation – putting one’s ideas first, trumpeting your merits, taking on risk – is most “un-Finnish”. But not to one Finn.

The EU’s top R&D administrator gives a preview of changes ahead for 2008 – including plans to increase the mobility of researchers.

Researchers and institutions in Germany and the UK dominate in the starting grants for independent research issued by the recently created European Research Council.

Alexander von Gabain and his team laid the foundations of an enterprise that would rise to the top of the continent’s biotechnology pile – and rewrite the region’s rules for biotechnology start-ups.

The spin-out tag makes university start-ups look weak and vulnerable, says Philip Sharpe from QinetiQ, one of Europe’s largest technology commercialisation companies.

Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.